Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

GuiLi Xu

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 22, 2014
MiR-142-3p represses TGF-β-induced growth inhibition through repression of TGFβR1 in non-small cell lung cancerZhe Lei, Guili Xu, Longqiang Wang, et al.
Comparative Medicine|April 18, 2023
Bioactivity and Pharmacodynamics of X002, A Follicle-Stimulating Hormone-IgG4 Fc Fusion ProteinGuili Xu, Yi Yang, Yunhui Liu, et al.
Journal of Pharmaceutical and Biomedical Analysis|April 28, 2009
Determination of bencycloquidium bromide in human urine using weak cation-exchange solid-phase extraction and LC-ESI-MS: Method validation and application to kinetic study of urinary excretionWenjia Zhou, Li Ding, Guili Xu, et al.
Molecules (Basel, Switzerland)|October 2, 2015
Potent Activities of Roemerine against Candida albicans and the Underlying MechanismsChaoyu Ma, Faya Du, Lan Yan, et al.
International Journal of Molecular Sciences|October 14, 2022
Anti-c-MET Fab-Grb2-Gab1 Fusion Protein-Mediated Interference of c-MET Signaling Pathway Induces Methuosis in Tumor CellsXiaoqian Dou, Qinzhi Xu, Bo Dong, et al.
Plos One|November 26, 2015
Roemerine Improves the Survival Rate of Septicemic BALB/c Mice by Increasing the Cell Membrane Permeability of Staphylococcus aureusSunjun Yin, Gaoxiong Rao, Jin Wang, et al.
Drugs in R&D|February 26, 2026
Preclinical Evaluation of AHT-102, a CLDN18.2 × CD3 Bispecific Antibody: Pharmacokinetics, Anti-Tumor Efficacy, Tissue Distribution, and Safety ProfileHuilun Chu, Guili Xu, Yunlong Liu, et al.
Cancer Cell International|April 16, 2021
Circular RNA hsa_circ_0003288 induces EMT and invasion by regulating hsa_circ_0003288/miR-145/PD-L1 axis in hepatocellular carcinomaGuili Xu, Peng Zhang, Hansi Liang, et al.
Immunobiology|October 5, 2022
Preclinical characterization of a Fab-like CD3/CLDN18.2 XFab® bispecific antibody against solid tumorsGuili Xu, Niliang Qian, Yujie Liu, et al.
Cancer Immunology, Immunotherapy : CII|October 20, 2023
XFab-α4-1BB/CD40L fusion protein activates dendritic cells, improves expansion of antigen-specific T cells, and exhibits antitumour efficacy in multiple solid tumour modelsBochun Wang, Yujie Liu, Ruofei Yuan, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 22, 2014
MiR-142-3p represses TGF-β-induced growth inhibition through repression of TGFβR1 in non-small cell lung cancerZhe Lei, Guili Xu, Longqiang Wang, et al.
Comparative Medicine|April 18, 2023
Bioactivity and Pharmacodynamics of X002, A Follicle-Stimulating Hormone-IgG4 Fc Fusion ProteinGuili Xu, Yi Yang, Yunhui Liu, et al.
Journal of Pharmaceutical and Biomedical Analysis|April 28, 2009
Determination of bencycloquidium bromide in human urine using weak cation-exchange solid-phase extraction and LC-ESI-MS: Method validation and application to kinetic study of urinary excretionWenjia Zhou, Li Ding, Guili Xu, et al.
Molecules (Basel, Switzerland)|October 2, 2015
Potent Activities of Roemerine against Candida albicans and the Underlying MechanismsChaoyu Ma, Faya Du, Lan Yan, et al.
International Journal of Molecular Sciences|October 14, 2022
Anti-c-MET Fab-Grb2-Gab1 Fusion Protein-Mediated Interference of c-MET Signaling Pathway Induces Methuosis in Tumor CellsXiaoqian Dou, Qinzhi Xu, Bo Dong, et al.
Plos One|November 26, 2015
Roemerine Improves the Survival Rate of Septicemic BALB/c Mice by Increasing the Cell Membrane Permeability of Staphylococcus aureusSunjun Yin, Gaoxiong Rao, Jin Wang, et al.
Drugs in R&D|February 26, 2026
Preclinical Evaluation of AHT-102, a CLDN18.2 × CD3 Bispecific Antibody: Pharmacokinetics, Anti-Tumor Efficacy, Tissue Distribution, and Safety ProfileHuilun Chu, Guili Xu, Yunlong Liu, et al.
Cancer Cell International|April 16, 2021
Circular RNA hsa_circ_0003288 induces EMT and invasion by regulating hsa_circ_0003288/miR-145/PD-L1 axis in hepatocellular carcinomaGuili Xu, Peng Zhang, Hansi Liang, et al.
Immunobiology|October 5, 2022
Preclinical characterization of a Fab-like CD3/CLDN18.2 XFab® bispecific antibody against solid tumorsGuili Xu, Niliang Qian, Yujie Liu, et al.
Cancer Immunology, Immunotherapy : CII|October 20, 2023
XFab-α4-1BB/CD40L fusion protein activates dendritic cells, improves expansion of antigen-specific T cells, and exhibits antitumour efficacy in multiple solid tumour modelsBochun Wang, Yujie Liu, Ruofei Yuan, et al.
Pageof 4